Samuel Lawrance Whittle

Samuel Lawrance Whittle

Auto-generated profile, based on publicly available information

Samuel Lawrance Whittle

Discipline of Rheumatology, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2003 in Rheumatology
Verified
Journal Article
Open access
PDF file
SWS. L. Whittle
S. L. Whittle
RHR. A. Hughes
R. A. Hughes
Objectives. The folate antagonist methotrexate (MTX) has become established as the most commonly used disease-modifying anti-rheumatic drug (DMARD) in the treatment of rheumatoid arthritis (RA) but is commonly discontinued due to adverse effects. Adverse effects are thought to be mediated via folate antagonism. In this paper we summarize the current data on the use of folates as a supplement to MTX use in RA for the prevention of adverse effects and as a potential modulator of cardiovascular risk, and propose guidelines for standard practice.

6 January 2015 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
SWSamuel Whittle
Samuel Whittle
RBRachelle Buchbinder
Rachelle Buchbinder
Shoulder pain is a common musculoskeletal disorder and has a substantial negative effect on quality of life. Its monthly prevalence in the general population is reported to be between 18% and 31%, whereas lifetime prevalence ranges between 6.7% and 66.7%. Shoulder pain is the third most frequent musculoskeletal reason to present to primary care and accounts for up to 10% of all referrals to physical therapists. Although the natural history of shoulder pain varies and is often self-limiting,up to half of persons who present for care, particularly the elderly, might continue to have pain and/or functional disturbance for up to 2 years after presentation.

24 March 2012 in Rheumatology
Verified
Journal Article
Open access
PDF file
SWSamuel L. Whittle
Samuel L. Whittle
ACAlexandra N. Colebatch
Alexandra N. Colebatch
RBRachelle Buchbinder
Rachelle Buchbinder
CEChristopher J. Edwards
Christopher J. Edwards
KAKaren Adams
Karen Adams
DHDésirée van der Heijde
Désirée van der Heijde
Objective. To develop evidence-based recommendations for pain management by pharmacotherapy in patients with inflammatory arthritis (IA). Methods. A total of 453 rheumatologists from 17 countries participated in the 2010 3e (Evidence, Expertise, Exchange) Initiative. Using a formal voting process, 89 rheumatologists representing all 17 countries selected 10 clinical questions regarding the use of pain medications in IA. Bibliographic fellows undertook a systematic literature review for each question, using MEDLINE, EMBASE, Cochrane CENTRAL and 2008–09 European League Against Rheumatism (EULAR)/ACR abstracts. Relevant studies were retrieved for data extraction and quality assessment. Rheumatologists from each country used this evidence to develop a set of national recommendations. Multinational recommendations were then formulated and assessed for agreement and the potential impact on clinical practice. Results. A total of 49 242 references were identified, from which 167 studies were included in the systematic reviews. One clinical question regarding different comorbidities was divided into two separate reviews, resulting in 11 recommendations in total. Oxford levels of evidence were applied to each recommendation. The recommendations related to the efficacy and safety of various analgesic medications, pain measurement scales and pain management in the pre-conception period, pregnancy and lactation. Finally, an algorithm for the pharmacological management of pain in IA was developed. Twenty per cent of rheumatologists reported that the algorithm would change their practice, and 75% felt the algorithm was in accordance with their current practice. Conclusions. Eleven evidence-based recommendations on the management of pain by pharmacotherapy in IA were developed. They are supported by a large panel of rheumatologists from 17 countries, thus enhancing their utility in clinical practice.

28 February 2019 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
LTLai-Shan Tam
Lai-Shan Tam
CHENGCHUNG WEICHENGCHUNG WEI
CHENGCHUNG WEI
AAAmita Aggarwal
Amita Aggarwal
HBHan Joo Baek
Han Joo Baek
PCPeter P. Cheung
Peter P. Cheung
Wallace Chak Sing LauWallace Chak Sing Lau
Wallace Chak Sing Lau

18 January 2012 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
BRBethan L Richards
Bethan L Richards
SWSamuel L Whittle
Samuel L Whittle
RBRachelle Buchbinder
Rachelle Buchbinder

6 March 2019 in Rheumatology
Verified
Journal Article
Closed access
MPMatthew J Page
Matthew J Page
DODenise A O’cOnnor
Denise A O’cOnnor
MMMary Malek
Mary Malek
RHRomi Haas
Romi Haas
DBDorcas Beaton
Dorcas Beaton
OGOMERACT Shoulder Core Set Working Group
OMERACT Shoulder Core Set Working Group
Objectives: To describe the experiences (including symptoms and perceived impacts on daily living) of people with a shoulder disorder. Methods: Systematic review of qualitative studies. We searched for eligible qualitative studies indexed in Ovid MEDLINE, Ovid Embase, CINAHL (EBSCO), SportDiscus (EBSCO) and Ovid PsycINFO up until November 2017. Two authors independently screened studies for inclusion, appraised their methodological quality using the Critical Appraisal Skills Programme checklist, used thematic synthesis methods to generate themes describing the experiences reported by participants and assessed the confidence in the findings using the Grading of Recommendations Assessment, Development and Evaluation Confidence in Evidence from Reviews of Qualitative research (GRADE-CERQual) approach. Results: The inclusion criteria were met by eight studies, which included 133 participants (49 females and 84 males) with either rotator cuff disease, adhesive capsulitis, proximal humeral fracture, shoulder instability or unspecified shoulder pain. We generated seven themes to describe what people in the included studies reported experiencing: pain; physical function/activity limitations; participation restriction; sleep disruption; cognitive dysfunction; emotional distress; and other pathophysiological manifestations (other than pain). There were interactions between the themes, with particular experiences impacting on others (e.g. pain leading to reduced activities and sleep disruption). Following grading of the evidence, we considered it likely that most of the review findings were a reasonable representation of the experiences of people with shoulder disorders. Conclusion: Patients with shoulder disorders contend with considerable disruption to their life. The experiences described should be considered by researchers seeking to select the most appropriate outcomes to measure in clinical trials and other research studies in people with shoulder disorders.